Synthetic molecule may treat anemia | Science News



Support credible science journalism.

Subscribe to Science News today.


Synthetic molecule may treat anemia

2:56pm, February 11, 2003

A hormone that regulates the production of red blood cells now comes in a synthetic version. The lab-made hormone could treat anemia in patients with cancer or kidney failure.

Known as erythropoietin (EPO), the natural protein is made in people's kidneys and is already available as a drug. However, most of this supply is made through genetic engineering techniques. Animal studies indicate that the new chemically manufactured EPO variant, called synthetic erythropoiesis protein (SEP), may work better in patients than the genetically engineered drug does, says Gerd Kochendoerfer of Gryphon Therapeutics in South San Francisco, Calif.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from this issue of Science News

From the Nature Index Paid Content